EuropaBio welcomes the European Health Union plan. The EU has indeed a critical role to play in public health and better crisis preparedness to address serious cross-border health threats and improving crisis management capacity.
This is a non-exhaustive list of over 200 genome-editing or viral vector related products and research projects, drawn from various resources and covering healthcare, industrial and agricultural biotech
The development of a vaccine or an antiviral treatment is a long and complex process. So why are we hearing that a vaccine against COVID-19 may be ready in a year from now, or even sooner?
A recent interview with Prof. Jennifer Doudna, a co-discoverer of the CRISPR-Cas9 system for genome editing, highlights potential applications of the technology to COVID-19.
The 30th anniversary of World Haemophilia Day helps to illustrate the importance to support the bleeding disorders community. Read our interview with Amanda Bok, CEO of the European Haemophilia Consortium (EHC) & Co-Chair of EuropaBio's Patients BioForum.
On the occasion of World PI Week we interviewed Johan Prevot, Executive Director of the International Patient Organisation for Primary Immunodeficiencies (IPOPI).
On the occasion of World Haemophilia Day we had the pleasure to interview Dr. Ian Winburn, Global Medical Lead within Pfizer’s Rare Disease Business Unit.